Novel antibacterial surgical sutures

OSPT正在开发一种用于医疗器械和植入物的丝质噬菌体生物材料，以减少高危患者手术部位感染的风险。医疗器械感染是外科手术后最具破坏性的并发症，目前的护理标准包括在诊断后使用抗生素治疗。市场上唯一的预防性抗菌技术是银、一般抗菌剂或抗生素涂层，所有这些都与对人类健康和环境的潜在毒性有关。该项目的目标是通过展示第一个设备的概念验证和完善市场路线来降低技术风险。该项目的产出将帮助OSPT与大公司建立伙伴关系，并筹集下一阶段的资金，以达到临床试验的准备程度。OSPT正在开发一种平台技术，该项目代表了许多外科领域产品管道的第一块垫脚石。

OSPT is developing a first of a kind silk-bacteriophage biomaterial for medical devices and implants, to reduce the risk of surgical site infections in patient populations most at risk. Medical device infections are the most devastating complications following surgical procedures, and the current standard of care involves treatment with antibiotics following diagnostic. The only preventative antimicrobial technologies on the market are silver, general antimicrobials or antibiotic coatings, all associated with potential toxicity to human health and the environment.The objective of this project is to de-risk the technology, by demonstrating proof-of-concept of a first device and refining the route to market. The outputs of this project will help OSPT establish partnerships with larger companies and raise the next phase of funds to reach clinical trial readiness.OSPT is developing a platform technology and this project represents the first stepping stone to the pipeline of products in many surgical fields.